Science and Enterprise

Tag: NIH

  • Clinical Trial to Test Varied Hypertension Drug Dosage

    Researchers at University of Rochester Medical Center in New York are testing if a lower dose of an common blood pressure medicine can provide the same benefits as a standard dose in people with mild hypertension. The new clinical trial is funded with a $1.9 million grant from the National Heart Lung and Blood Institute,…

  • Computer Model to Predict Hip Fracture Risk

    Researchers at University of Arizona in Tucson are developing a computer model to predict which people are most at risk of a hip fracture. The study, led by engineering professor Samy Missoum and epidemiology and biostatistics professor Zhao Chen (pictured left), is funded by a two year, $357,982 grant from the National Institute of Arthritis…

  • NIH, Eli Lilly to Partner on Drug Effects Profiles

    National Institutes of Health and Eli Lilly and Company will produce a public resource that catalogs the effects of thousands of approved and investigational medicines in a variety of testing systems. Biological profiles of these medicines and molecules are expected to help biomedical researchers better predict treatment outcomes and improve drug development. NIH’s new National…

  • NIH Grant to Fund R&D on Pain Meds With Fewer Side Effects

    Scripps Research Institute in Jupiter, Florida has received a grant from National Institute on Drug Abuse, part of National Institutes of Health (NIH), for research on compounds that lead to new pain medications without the side effects of opiate drugs. The five-year, $3.1 million award will support a Scripps team led by neuroscientist Laura Bohn…

  • Warfarin, Aspirin Provide Similar Stroke Prevention

    In a six-year, 11-country clinical trial, researchers at Columbia University found aspirin and the anti-clotting drug warfarin to offer about equal protection against death and strokes in heart failure patients with normal heart rhythms. The findings of the study led by Columbia medical school professor Shunichi Homma were presented at the International Stroke Conference in…

  • NIH Trials to Assess Emergency Cardiac Arrest Treatments

    NIH’s National Heart, Lung, and Blood Institute has begun two clinical trials to evaluate treatments for out-of-hospital cardiac arrest: – A comparison of continuous chest compressions (CCC) combined with pause-free rescue breathing, to standard cardiopulmonary resuscitation (CPR) that includes a combination of chest compressions and pauses for rescue breathing, and – Treatment with the drug…

  • NIH Funds Study of Chemical Effects on Adult Stem Cells

    Bioengineers at Rensselaer Polytechnic Institute in Troy, New York and University of California at Berkeley, have been awarded a grant from  National Institutes of Health (NIH) to study how chemicals in drugs and the environment affect human stem cells. The four-year grant of more than $2 million will fund teams led by Rensselaer’s chemical and…

  • NIH Establishes Medical Translational Science Center

    The federal 2012 fiscal year spending bill passed by Congress and signed by President Obama before Christmas includes approval for National Institutes of Health (NIH) to form a new research center devoted to turning discoveries in the lab into new drugs, diagnostics, and devices. The National Center for Advancing Translational Sciences (NCATS), with a budget…

  • Genome Institute to Fund Research on Rare Diseases, Medical Care

    Funding announced by the National Human Genome Research Institute (NHGRI), part of National Institutes of Health, will support new research on rare inherited diseases, informatics tools, and use of genomic data in medical care delivery. The four-year, $416 million plan also continues funding for current initiatives on large-scale genomic sequencing production. NHGRI plans to award…

  • NIH Unveils Web Site to Expedite Lab Technology Transfer

    National Institutes of Health has launched its electronic Research Materials (eRMa) Web site that aims to make it easier for prospects to locate and license findings from NIH’s labs for commercialization. The eRMA site was developed in response to President Obama’s order to agencies last month to speed the process of transferring federal scientific discoveries…